PLAN B Showcases its Design Prowess

Friday, October 30 2015 | 00 h 00 min | New Products

The Glacee collection is creating exclusive limited availability ultralux sunglass models. These models will encapsulate the creativity that is synonymous with the Glacee brand, unique, vast in style, shapes and colours. The latest exclusive model in this collection is the GL6720.

Ice Cream, also from Plan “B” Eyewear, creates two new models, the IC9013 and IC9020. IC9013 is designed for the petite woman, with a colour application that is completely proprietary and revolutionary to create a distinguished piece of art for the empty canvas, our face.

Distributed by Plan B Eyewear: www.planbeyewear.com

Featured Posts

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more

Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more

Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read More

Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read More

Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read More

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read More

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more

Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more

Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO)

Learn More

OneSight EssilorLuxottica Foundation Joins Forces with WHO to Advance Global Vision Care Under WHO SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

Read more

Silmo Optical Design Contest 2025

Optics 2025 Design Contest: See Beyond & Reveal!

SILMO Paris, a key event in the optics and eyewear sector since 1967, is inviting design students to take up a unique challenge with the 4th edition of the Optical Design Contest.

Read more

Voila November-December 2024 Lanctôt Optical Kaleos Danforth

Kaleos Men: The Technical Era

Kaleos is introducing this season Danforth, a rectangular aviator-style optical frame combining a thick titanium front and a high-density acetate trim.

Read more

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.

Read more